• Ponericin-Q42 (insects, arthropods, invertebrates, animals, UCLL1a) peptide

Ponericin-Q42 (insects, arthropods, invertebrates, animals, UCLL1a) peptide

Not For Human Use, Lab Use Only.

Cat.#: 300522

Special Price 341.60 USD

Availability: 3 weeks
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Ponericin-Q42 (insects, arthropods, invertebrates, animals, UCLL1a) peptide
  • Documents
  • Sequence Shortening
    H-FWGAVWKILSKVLPHIPGTVKWLQEKV-OH
  • Sequence
    H-Phe-Trp-Gly-Ala-Val-Trp-Lys-Ile-Leu-Ser-Lys-Val-Leu-Pro-His-Ile-Pro-Gly-Thr-Val-Lys-Trp-Leu-Gln-Glu-Lys-Val-OH
  • Length (aa)
    27
  • Peptide Purity (HPLC)
    95.69%
  • Molecular Formula
    C156H239N37O33
  • Molecular Weight
    3160.78
  • Source
    Synthetic
  • Form
    Powder
  • Description
    Ponericin-Q42 is a linear antimicrobial peptide isolated from the venom of the ant species Ectatomma quadridens. It is one of three peptides with low similarity to the well-known ponericin peptides found in the ant venom.
    The peptide has a partially helical secondary structure, even in aqueous environments, which is unusual for short linear peptides.
    Ponericin-Q42 has been shown to possess marked antibacterial activity against both Gram-positive and Gram-negative bacteria at low micromolar concentrations. For example, it is active against A. globiformis VKM Ac-1112, B. subtilis VKM B-501, E. coli MH1 (MIC 0.2-0.6 uM), E. coli DH5a, and P. aeruginosa PAO1 (MIC 5-10 uM). It also exhibits broad-spectrum cytolytic activity against different bacterial strains, human erythrocytes, and chronic myelogenous leukemia K562 cells. Ponericin-Q42 also has weak toxic activity on flesh fly larvae, with an LD50 of approximately 105 mg/g.
  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Pluzhnikov KA, Kozlov SA, Vassilevski AA, Vorontsova OV, Feofanov AV, Grishin EV. Linear antimicrobial peptides from Ectatomma quadridens ant venom. Biochimie. 2014;107 Pt B:211-5.
    • Kozic M, Fox SJ, Thomas JM, Verma CS, Rigden DJ. Large scale ab initio modeling of structurally uncharacterized antimicrobial peptides reveals known and novel folds. Proteins. 2018 May;86(5):548-565.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator

  • Dilution Calculator

  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"